1-225507964-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_018212.6(ENAH):​c.1525C>T​(p.Pro509Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000214 in 1,403,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

ENAH
NM_018212.6 missense

Scores

2
7
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.80

Publications

0 publications found
Variant links:
Genes affected
ENAH (HGNC:18271): (ENAH actin regulator) This gene encodes a member of the enabled/ vasodilator-stimulated phosphoprotein. Members of this gene family are involved in actin-based motility. This protein is involved in regulating the assembly of actin filaments and modulates cell adhesion and motility. Alternate splice variants of this gene have been correlated with tumor invasiveness in certain tissues and these variants may serve as prognostic markers. A pseudogene of this gene is found on chromosome 3. [provided by RefSeq, Sep 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.28785437).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ENAHNM_018212.6 linkc.1525C>T p.Pro509Ser missense_variant Exon 11 of 14 ENST00000366843.7 NP_060682.2 Q8N8S7-2A0A4D6J698

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENAHENST00000366843.7 linkc.1525C>T p.Pro509Ser missense_variant Exon 11 of 14 1 NM_018212.6 ENSP00000355808.2 Q8N8S7-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000954
AC:
2
AN:
209540
AF XY:
0.0000174
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000983
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000214
AC:
3
AN:
1403746
Hom.:
0
Cov.:
28
AF XY:
0.00000287
AC XY:
2
AN XY:
697674
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
30182
American (AMR)
AF:
0.00
AC:
0
AN:
31492
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24268
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37814
South Asian (SAS)
AF:
0.0000135
AC:
1
AN:
74058
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51548
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4138
European-Non Finnish (NFE)
AF:
0.00000183
AC:
2
AN:
1092664
Other (OTH)
AF:
0.00
AC:
0
AN:
57582
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.038550), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 22, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1525C>T (p.P509S) alteration is located in exon 11 (coding exon 11) of the ENAH gene. This alteration results from a C to T substitution at nucleotide position 1525, causing the proline (P) at amino acid position 509 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Uncertain
0.095
D
BayesDel_noAF
Benign
-0.10
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.11
T;.;.
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D;D;D
M_CAP
Benign
0.050
D
MetaRNN
Benign
0.29
T;T;T
MetaSVM
Uncertain
0.051
D
MutationAssessor
Benign
0.55
N;.;N
PhyloP100
8.8
PrimateAI
Pathogenic
0.79
T
PROVEAN
Benign
-1.8
N;.;N
REVEL
Benign
0.28
Sift
Benign
0.75
T;.;T
Sift4G
Benign
0.48
T;T;T
Polyphen
0.98
D;.;D
Vest4
0.48
MutPred
0.20
Gain of phosphorylation at P509 (P = 0.0264);.;Gain of phosphorylation at P509 (P = 0.0264);
MVP
0.61
MPC
0.75
ClinPred
0.94
D
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.21
gMVP
0.59
Mutation Taster
=25/75
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs746347122; hg19: chr1-225695666; API